BackgroundCheck.run
Search For

Brian Ault Ault, 6816693 Blue Marlin Ct, Lewes, DE 19958

Brian Ault Phones & Addresses

16693 Blue Marlin Ct, Lewes, DE 19958    610-2867820   

Winthrop, ME   

New Gloucester, ME   

New York, NY   

117 Ponds Ln, Wilmington, DE 19807   

Greenville, DE   

Elverson, PA   

Malvern, PA   

Rensselaer, NY   

Pottstown, PA   

North Potomac, MD   

Mentions for Brian Ault Ault

Publications & IP owners

Us Patents

Treatment Of Psychoses With Dibenzothiazepine Antipsychotic

US Patent:
2005017, Aug 4, 2005
Filed:
Jan 26, 2005
Appl. No.:
11/043622
Inventors:
Brian Ault - Wilmington DE, US
Gilbert Block - Wilmington DE, US
Martin Brecher - Wilmington DE, US
Wayne MacFadden - Wilmington DE, US
Robin McCoy - Wilimington DE, US
Margaret Minkwitz - Wilmington DE, US
Jamie Mullen - Wilmington DE, US
Ellis Wilson - Wilmington DE, US
International Classification:
A61K031/554
US Classification:
514211130
Abstract:
The present invention provides methods for treating depression symptoms associated with bipolar disorder.

Method For Delivering A Pharmaceutical Composition To Patient In Need Thereof

US Patent:
2010006, Mar 11, 2010
Filed:
Sep 3, 2009
Appl. No.:
12/553107
Inventors:
Brian Ault - Wilmington DE, US
Mark Sostek - Wilmington DE, US
Everardus Orlemans - Chapel Hill NC, US
John R. Plachetka - Chapel Hill NC, US
Assignee:
ASTRAZENECA UK LTD. - London
POZEN INC. - Chapel Hill NC
International Classification:
A61K 9/30
A61K 31/4439
A61P 29/00
A61P 19/02
US Classification:
424475, 514338
Abstract:
The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof

Treatment Of Psychoses With Dibenzothiazepine Antipsychotic

US Patent:
2010031, Dec 9, 2010
Filed:
Aug 17, 2010
Appl. No.:
12/857897
Inventors:
Brian Ault - Wilmington DE, US
Gilbert Block - Wilmington DE, US
Martin Brecher - Wilmington DE, US
Wayne MacFadden - Wilmington DE, US
Robin McCoy - Wilmington DE, US
Margaret Minkwitz - Wilmington DE, US
Jamie Mullen - Wilmington DE, US
Ellis Wilson - Wilmington DE, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/554
C07D 281/16
A61P 25/24
A61P 25/22
A61P 25/00
A61P 25/18
US Classification:
51421113, 540551
Abstract:
The present invention provides methods for treating depression symptoms associated with bipolar disorder.

Method For Treating A Patient At Risk For Developing An Nsaid-Associated Ulcer

US Patent:
2010033, Dec 30, 2010
Filed:
Jun 24, 2010
Appl. No.:
12/822612
Inventors:
Brian Ault - Wilmington DE, US
Clara Hwang - Wilmington DE, US
Everardus Orlemans - Chapel Hill NC, US
John R. Plachetka - Chapel Hill NC, US
Mark Sostek - Wilmington DE, US
Assignee:
ASTRAZENECA AB - Sodertalje
POZEN INC. - Chapel Hill NC
International Classification:
A61K 9/24
A61K 31/4439
A61K 9/30
A61K 9/36
A61P 1/04
A61P 29/00
A61P 19/02
US Classification:
424472, 514338, 424475, 424479
Abstract:
The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.